Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma

Bibliographic Details
Main Authors: Sridurga Mithraprabhu, John Reynolds, Rose Turner, Hang Quach, Noemi Horvath, Ian Kerridge, Anna Kalff, Krystal Bergin, Jay Hocking, Flora Yuen, Tiffany Khong, Brian M. Durie, Andrew Spencer
Format: Article
Language:English
Published: Nature Publishing Group 2023-02-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-023-00796-9
_version_ 1797865525910437888
author Sridurga Mithraprabhu
John Reynolds
Rose Turner
Hang Quach
Noemi Horvath
Ian Kerridge
Anna Kalff
Krystal Bergin
Jay Hocking
Flora Yuen
Tiffany Khong
Brian M. Durie
Andrew Spencer
author_facet Sridurga Mithraprabhu
John Reynolds
Rose Turner
Hang Quach
Noemi Horvath
Ian Kerridge
Anna Kalff
Krystal Bergin
Jay Hocking
Flora Yuen
Tiffany Khong
Brian M. Durie
Andrew Spencer
author_sort Sridurga Mithraprabhu
collection DOAJ
first_indexed 2024-04-09T23:09:31Z
format Article
id doaj.art-395946072e064febb163a360698ca78a
institution Directory Open Access Journal
issn 2044-5385
language English
last_indexed 2024-04-09T23:09:31Z
publishDate 2023-02-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj.art-395946072e064febb163a360698ca78a2023-03-22T10:27:59ZengNature Publishing GroupBlood Cancer Journal2044-53852023-02-011311510.1038/s41408-023-00796-9Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myelomaSridurga Mithraprabhu0John Reynolds1Rose Turner2Hang Quach3Noemi Horvath4Ian Kerridge5Anna Kalff6Krystal Bergin7Jay Hocking8Flora Yuen9Tiffany Khong10Brian M. Durie11Andrew Spencer12Australian Centre for Blood Diseases, Alfred Health—Monash UniversityAustralian Centre for Blood Diseases, Alfred Health—Monash UniversityDepartment of Malignant Haematology and Stem Cell Transplantation, Alfred HospitalSt.Vincent’s Hospital, University of MelbourneRoyal Adelaide HospitalRoyal North Shore HospitalDepartment of Malignant Haematology and Stem Cell Transplantation, Alfred HospitalAustralian Centre for Blood Diseases, Alfred Health—Monash UniversityDepartment of Malignant Haematology and Stem Cell Transplantation, Alfred HospitalDepartment of Malignant Haematology and Stem Cell Transplantation, Alfred HospitalAustralian Centre for Blood Diseases, Alfred Health—Monash UniversityCedars-Sinai Comprehensive Cancer CenterAustralian Centre for Blood Diseases, Alfred Health—Monash Universityhttps://doi.org/10.1038/s41408-023-00796-9
spellingShingle Sridurga Mithraprabhu
John Reynolds
Rose Turner
Hang Quach
Noemi Horvath
Ian Kerridge
Anna Kalff
Krystal Bergin
Jay Hocking
Flora Yuen
Tiffany Khong
Brian M. Durie
Andrew Spencer
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
Blood Cancer Journal
title Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_full Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_fullStr Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_full_unstemmed Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_short Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
title_sort circulating tumour dna analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
url https://doi.org/10.1038/s41408-023-00796-9
work_keys_str_mv AT sridurgamithraprabhu circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT johnreynolds circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT roseturner circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT hangquach circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT noemihorvath circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT iankerridge circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT annakalff circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT krystalbergin circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT jayhocking circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT florayuen circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT tiffanykhong circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT brianmdurie circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma
AT andrewspencer circulatingtumourdnaanalysispredictsrelapseandimprovesriskstratificationinprimaryrefractorymultiplemyeloma